Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Archive

Pages:

  • A Sitemap for LambLawOffice.com
  • About Our Firm
  • Alabama: Medical Records Copying Charges Law / Statute
  • Alaska: Medical Records Copying Charges Law / Statute
  • Archive
  • Arizona: Medical Records Copying Charges Law / Statute
  • Arkansas: Medical Records Copying Charges Law / Statute
  • Asbestos & Mesothelioma Overview
  • Asbestos Claims: How Do I Get Legal Compensation?
  • Attorney Profile: Thomas J. Lamb
  • Benzene Cancer Resources
  • Benzene Case Evaluation Form
  • Benzene Cases Overview
  • Benzene Exposure
  • Benzene Exposure and AML
  • Benzene Exposure and MDS
  • Benzene Exposure in Industries
  • Benzene-Containing Products
  • Benzene-Related Diseases
  • Benzene: Frequently Asked Questions
  • Blog
  • Breast Implant and Lymphoma: Resources
  • Breast Implant and Lymphoma: Summary of Information
  • Breast Implants and Lymphoma FAQs: About the Disease
  • Breast Implants and Lymphoma FAQs: Prognosis
  • Breast Implants and Lymphoma FAQs: Risk Factors
  • Breast Implants and Lymphoma FAQs: Symptoms
  • Breast Implants and Lymphoma FAQs: Treatment
  • Breast Implants and Lymphoma: FDA Information
  • Breast Implants and Lymphoma: Frequently Asked Questions
  • Breast Implants and Lymphoma: The Disease
  • Breast Implants Cancer Case Evaluation Form
  • Breast Implants Cases Overview
  • California: Medical Records Copying Charges Law / Statute
  • Case Evaluation Explanation
  • Case Evaluation Menu
  • Class Action vs. Individual Lawsuits
  • Colorado: Medical Records Copying Charges Law / Statute
  • Connecticut: Medical Records Copying Charges Law / Statute
  • Contact Us
  • Current Drug Injury Litigations
  • Delaware: Medical Records Copying Charges Law / Statute
  • Directions to Our Office at Lumina Station
  • Disclaimer and Copyright Notices
  • District of Columbia: Medical Records Copying Charges Law / Statute
  • Drug Injury Cases Overview
  • ED Drugs (as well as BPH and PAH drugs)
  • Florida: Medical Records Copying Charges Law / Statute
  • Frequently Asked Questions
  • General Case Evaluation Form
  • GenX Cancer Case Evaluation Form
  • GenX Cancers Overview
  • GenX Contamination of Fayetteville Well Water: Who is at Risk?
  • GenX Research Sources
  • Georgia: Medical Records Copying Charges Law / Statute
  • Hawaii: Medical Records Copying Charges Law / Statute
  • Heartburn and Acid Reflux Drugs
  • Hepatitis C Treatment Drugs – DAAs
  • How Payment for Our Legal Services Works
  • How to File a Benzene Workers Compensation Claim in NC
  • Idaho: Medical Records Copying Charges Law / Statute
  • Illinois: Medical Records Copying Charges Law / Statute
  • Incretin Mimetic Drugs
  • Indiana: Medical Records Copying Charges Law / Statute
  • Iowa: Medical Records Copying Charges Law / Statute
  • Kansas: Medical Records Copying Charges Law / Statute
  • Kentucky: Medical Records Copying Charges Law / Statute
  • Lamb Law Blog
  • Learn More About How We Work
  • Louisiana: Medical Records Copying Charges Law / Statute
  • Maine: Medical Records Copying Charges Law / Statute
  • Maryland: Medical Records Copying Charges Law / Statute
  • Massachusetts: Medical Records Copying Charges Law / Statute
  • Medical Records Copying Charges
  • Medical Records Costs Update 2020: 21st Century Cures Act Amends “Patient Rates” Aspect of HITECH
  • Mesothelioma and Asbestos Lawsuits
  • Mesothelioma, Asbestos, and Legal Compensation: Basic Facts
  • Michigan: Medical Records Copying Charges Law / Statute
  • Minnesota: Medical Records Copying Charges Law / Statute
  • Mississippi: Medical Records Copying Charges Law / Statute
  • Missouri: Medical Records Copying Charges Law / Statute
  • Montana: Medical Records Copying Charges Law / Statute
  • NC Workers Compensation Benzene Disease Claims Filing Deadline
  • Nebraska: Medical Records Copying Charges Law / Statute
  • Nevada: Medical Records Copying Charges Law / Statute
  • New Hampshire: Medical Records Copying Charges Law / Statute
  • New Jersey: Medical Records Copying Charges Law / Statute
  • New Mexico: Medical Records Copying Charges Law / Statute
  • New York: Medical Records Copying Charges Law / Statute
  • North Carolina: Medical Records Copying Charges Law / Statute
  • North Dakota: Medical Records Copying Charges Law / Statute
  • Ohio: Medical Records Copying Charges Law / Statute
  • Oklahoma: Medical Records Copying Charges Law / Statute
  • Oregon: Medical Records Copying Charges Law / Statute
  • Our Investigation of Your Case
  • Pennsylvania: Medical Records Copying Charges Law / Statute
  • Practice Areas
  • Quick Contact Form
  • Reporting Adverse Drug Reactions To The FDA MedWatch Program
  • Resources: Legal, Medical, and More
  • Rhode Island: Medical Records Copying Charges Law / Statute
  • September 2017: New GenX Information Soon to be Released
  • Sitemap for All Website Pages
  • South Carolina: Medical Records Copying Charges Law / Statute
  • South Dakota: Medical Records Copying Charges Law / Statute
  • Tennessee: Medical Records Copying Charges Law / Statute
  • Texas: Medical Records Copying Charges Law / Statute
  • Thank You For Allowing Us To Review Your Possible Case
  • Thank You for Completing Our Form
  • Thomas J. Lamb – Drug Injury, Asbestos Mesothelioma, Benzene Cancers
  • Timeline: GenX Contamination of the Cape Fear River
  • Timeline: GenX Study Results
  • Type 2 Diabetes Drugs (DPP-4 Inhibitors)
  • Type 2 Diabetes Drugs (SGLT-2 Inhibitors)
  • Utah: Medical Records Copying Charges Law / Statute
  • Vermont: Medical Records Copying Charges Law / Statute
  • Virginia: Medical Records Copying Charges Law / Statute
  • Washington: Medical Records Copying Charges Law / Statute
  • We Will Not Pressure or Rush You to Sign Our Contract of Representation
  • West Virginia: Medical Records Copying Charges Law / Statute
  • What are Mesothelioma, Asbestos Lung Cancer, and Asbestosis?
  • What is Asbestos?
  • What We Know About GenX
  • While We Are Working on Your Case
  • Wisconsin: Medical Records Copying Charges Law / Statute
  • Workers Who Could Be Exposed to Benzene
  • Wyoming: Medical Records Copying Charges Law / Statute
  • Your Drug Injury Case Review

Categories:

  • Asbestos
  • GenX
  • Mesothelioma
  • Uncategorized
  • Unsafe Drugs
  • Unsafe Medical Devices

Authors:

  • Legal Assistant (1)
  • Thomas Lamb (498)

Monthly:

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016

Recent Posts:

  • Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial
  • Talc-Based Beauty Products Found to be Contaminated With Asbestos
  • Elmiron Legal Cases for Eye Damage and Retinal Injury Are Consolidated in Elmiron MDL
  • Additional PFAS Testing Petition Denied by the EPA
  • Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?
  • Elmiron Updates: Legal, Medical, and Regulatory – December 2020
  • BIA-ALCL Case Studies Confirm Importance of Proper Treatment
  • Beovu Retinal Vasculitis Made Worse by a Later Lucentis Treatment
  • Beovu-related Retinal Vasculitis and Beovu Vision Loss Cases
  • Chemo-Free Regimen Boosts OS in Mesothelioma
  • Beovu Injections Side Effects: Novartis Points Out Risk Factors and Possible Causes in November 2020 Report
  • Dying Patients Denied Justice Amid COVID-Related Court Delays
  • Gilenya Linked To Acute Liver Failure, Drug-induced Liver Injury
  • PFAS Levels in Cape Fear Remain Largely the Same, Despite Emission Cuts
  • Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case–control study in the USA, 1975–1980
  • Beovu Legal Cases: Compensation for Eye Problems from Beovu Use
  • Global Picato Recall Due to Picato Skin Cancer Risk Findings Update
  • Stelara-associated Cardiovascular Events: Emerging Drug Safety Issue
  • Black Box Warning Label Change for Breast Implants Finalized by the FDA
  • Biomarker candidates could aid in earlier diagnosis of mesothelioma
  • Ocaliva Drug Label Warnings vis-à-vis FDA Ocaliva Safety Signal Investigation
  • A multicentre randomised phase III trial comparing pembrolizumab vs single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
  • Current Ocaliva Liver Safety FDA Evaluation Started Back in May 2020
  • FDA Approves Drug Combination for Treating Mesothelioma
  • Beovu-associated Endophthalmitis is “New” for Beovu Eye Drug Safety Issue of Vision Loss
  • Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
  • Beovu Use Continues Despite Ongoing Beovu-associated Inflammation Investigation
  • Safety of Beovu Update: Study Results Announcement by Novartis and Beovu Label Change in Europe
  • FDA clears IND application for CAR T-cell therapy for advanced mesothelioma
  • FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
  • Phase I Study of Novel Drug Shows Preliminary Activity in Mesothelin-Expressing Tumors
  • Are Elmiron Side Effects Risks for Eye and Vision Are Greater Than Its Bladder Treatment Benefits?
  • Chemours GenX Contamination Case Reaches New Deal
  • Elmiron Lawsuits Being Filed Against Drug Companies for Elmiron-Related Eye Problems
  • Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup
  • New BIA-ALCL Cases Identified in Updated FDA Report
  • Chemical Firm BASF and Its Law Firm to Pay $72.5M to Close Talcum-Asbestos Claims
  • VEGF Inhibitors Class Of Drugs: Risks Of Aneurysm And Artery Dissection
  • Clinical Practice Guidelines for the Management of Malignant Pleural Mesothelioma
  • Nivolumab/Ipilimumab Demonstrates Durable OS Benefit in Malignant Pleural Mesothelioma
  • After Two Injections Of Beovu, Retinal Vasculitis With Vision Loss
  • Private Settlement Reached in Mesothelioma Case
  • Beovu | July 2020 | Current Findings For Occlusive Vasculitis And Vision Loss
  • PFAS Contamination of the Cape Fear Still An Issue
  • Most American Women Are Unaware of BIA-ALCL
  • Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis
  • When Will FDA Weigh-in On The Picato Skin Cancer Safety Issue?
  • Study finds drug beneficial for shrinking mesothelioma tumors
  • Beovu: External Safety Review Committee Findings Lead To New Vision-Related Side Effects Warnings
  • [Transforming Growth Factor Alpha] Promotes Chemoresistance of Malignant Pleural Mesothelioma
  • Allergan Aesthetics Launches Tracking Campaign for U.S. Breast Implant Patients
  • New Beovu Warnings About Risks Of Retinal Vasculitis And Retinal Vascular Occlusion
  • Johnson & Johnson to stop selling talc baby powder in U.S. and Canada
  • Zantac Recall: Chemical NDMA In Zantac Pills Can Cause Cancers
  • Chemours’ PFAS Chemical Reduction Plans: Are They Enough?
  • Imerys signs agreement to end talc litigation in the United States
  • After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
  • A dying wish for schools
  • Advances Made in Understanding and Treatment of BIA-ALCL
  • Lemtrada Side Effects Now Include Lemtrada Causing ANCA-Associated Vasculitis
  • Bristol Myers Squibb’s Opdivo-Yervoy combo helps mesothelioma patients live longer
  • Picato Skin Cancer Risk Confirmed In Europe; FDA Picato Review Ongoing
  • Asbestos inhalation poses cancer risks to workers and consumers
  • Beovu Vision Loss And Retinal Vasculitis Cases May Lead To New Warnings
  • EPA finds asbestos poses cancer risks for workers, reigniting calls for ban
  • Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
  • Xeljanz Side Effects Include Blood Clots, Pulmonary Embolism, And Serious Infections
  • Montana Supreme Court: BNSF Not Shielded from Liability in Libby Asbestos Cases
  • Asbestos Warnings Grow With Penn State Lawsuit, National Push
  • Lemtrada-Related Cardiovascular Reactions And Immune-Mediated Reactions
  • The Role of Neoadjuvant Chemotherapy in Patients with Resectable Malignant Pleural Mesothelioma – An Institutional and National Analysis
  • Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature
  • Beovu Warning For Retinal Vasculitis: Is Current Drug Label Sufficient “As Is”?
  • Philly School District poised to pay $850K to teacher diagnosed with mesothelioma
  • Beovu Warning: Retinal Vasculitis Which Can Lead To Blindness / Vision Loss
  • Injectafer Drug Label Change Adds New Hypophosphatemia Warning
  • Lurbinectedin as Second- or Third-Line Palliative Therapy in Malignant Pleural Mesothelioma
  • Where GenX and Other PFAS Chemicals are Recently Being Detected
  • Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung
  • Statute of Repose Bars Asbestos-related Claim by Former Power Plant Worker
  • Hypophosphatemia Associated With Injectafer Compared To Another Intravenous Anemia Drug
  • Malignant Diffuse Mesothelioma in Women — A Study of 354 Cases
  • FDA to hold public meeting on testing for asbestos in talc
  • Hypophosphatemia Is An Injectafer Side Effect With Possible Serious Medical Complications Including Death
  • US FDA stands by asbestos talc results following J&J error claims
  • Picato: Investigation Of Skin Cancer Risk By European Drug Regulator EMA
  • J&J CEO to testify at trial for first time on Baby Powder risks
  • Cancer Linked to Breast Implants: Is it Considered Rare Anymore?
  • State Proposes ‘Asbestos Watch Area’ Near Old Davidson Mill
  • Uloric-Related Acute Kidney Injury And Acute Renal Failure Pointed Out In Safety Study
  • Study uncovers novel targetable axis in mesothelioma patients
  • Weight-Loss Medicine Belviq Increased Risk Of Cancers Says FDA Drug Safety Communication
  • Government experts urge new talc testing standards amid asbestos worries
  • Ranitidine In Zantac Might Produce NDMA As A Result Of Heat Effect
  • J&J settles California baby powder-cancer case in the middle of jury trial
  • Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma
  • 50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience
  • Warning About Gilenya Birth Defects From Health Canada In December 2019
  • An analysis of workplace exposures to asbestos at three steel mills located in the United States (1972-1982)
  • Possible Public Health Issue For Hemlibra Used By Hemophilia A Patients

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.